We started the treatment on 26th November 2010 following the recommended dosage. We started to notice some positive improvements. although there were not very significant at the beginning. They started to accentuate more throughout the treatment: the spasticity was reduced, the sense of orientation increased as well as speaking and movement capability at the end of the first month of treatment.
Liliana Castaño Muñoz (Colombia)
Kurt Stiles (Minnesota, EEUU)
Suzanne M. Fisher (Sacramento, California, EE.UU.)
